InsidersTradesSigma
대화제약: directors' dealings · South Korea · DART (FSS)
DART:company-504229KR·DART (FSS)Mcap 237.4Bn€Healthcare
Explore the full management transaction log of 대화제약, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Healthcare sector, 대화제약 has recorded 5 insider filings. Market capitalisation: €237.4bn. The latest transaction was disclosed on 14 May 2026 — Purchase. Among the most active insiders: 김은석. All data is openly available.
5
Insider Decl.
0
Thresholds
€60,856
3 ops.
Buy Volume
€29,868
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
13550.00 €
Analyst consensus
Income statement
Revenue143.06 Bn€
Gross profit47.83 Bn€33% margin
Net income1.65 Bn€1.2% margin
Valuation
Beta-0.08
Balance sheet & cash
Market cap237.35 Bn€
Total debt96.78 Bn€
Free Cash Flow699.9 M€
Debt / Equity122%
Profitability & ownership
ROE3.0%
ROA0.9%
% insiders26.6%
% institutions2.7%
Last declaration on 14 May 2026
Declarations5 total
5 of 5 declarations